Effects of 12-wk Lactobacillus plantarum OLL2712 treatment on glucose metabolism and chronic inflammation in prediabetic individuals: A single-arm pilot study
•Lactobacillus plantarum OLL2712 is effective for individuals who are prediabetic.•The ingestion of OLL2712 cells significantly improved fasting plasma glucose levels.•Serum glycoalbumin levels and insulin resistance indexes were improved.•The intervention also suppressed serum monocyte chemotactic...
Gespeichert in:
| Veröffentlicht in: | Nutrition (Burbank, Los Angeles County, Calif.) Los Angeles County, Calif.), 2019-02, Vol.58, p.175-180 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 180 |
|---|---|
| container_issue | |
| container_start_page | 175 |
| container_title | Nutrition (Burbank, Los Angeles County, Calif.) |
| container_volume | 58 |
| creator | Toshimitsu, Takayuki Gotou, Ayako Furuichi, Keisuke Hachimura, Satoshi Asami, Yukio |
| description | •Lactobacillus plantarum OLL2712 is effective for individuals who are prediabetic.•The ingestion of OLL2712 cells significantly improved fasting plasma glucose levels.•Serum glycoalbumin levels and insulin resistance indexes were improved.•The intervention also suppressed serum monocyte chemotactic protein-1 and interleukin-6 levels.•OLL2712 might exert anti-diabetic effects by suppressing chronic inflammation.
Previously, we demonstrated that the administration of heat-killed OLL2712 cells suppressed chronic inflammation and improved hyperglycemia in a mouse model of obesity and diabetes. The aim of this study was to preliminarily examine the effect of OLL2712 supplementation on glucose metabolism and chronic inflammation in prediabetic subjects.
This study was a prospective, 12-wk, single-arm, open trial, followed by a 4-wk posttreatment period. Inclusion criteria were fasting plasma glucose levels of 105 to 130 mg/dL in an age range of 35 to 65 y. Thirty individuals consumed a dairy beverage containing ∼1 × 1010 heat-killed OLL2712 cells for 12 wk.
The ingestion of the OLL2712 beverage significantly improved fasting plasma glucose levels, serum glycoalbumin levels, and insulin resistance indexes compared with baseline levels. The intervention also suppressed serum monocyte chemotactic protein-1 and interleukin-6 levels, which are proinflammatory cytokines involved in the development of insulin resistance and hyperglycemia. Furthermore, stratified analysis by these proinflammatory cytokine levels revealed that the beneficial effects of OLL2712 beverage were observed particularly in individuals with chronic inflammation at baseline.
The results of this study suggested that heat-killed OLL2712 cells have the potential to improve insulin resistance and glucose metabolism by suppressing chronic inflammation. |
| doi_str_mv | 10.1016/j.nut.2018.07.116 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2149016490</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0899900718309298</els_id><sourcerecordid>2149016490</sourcerecordid><originalsourceid>FETCH-LOGICAL-c447t-753536d9c44b0365723d69b3a7c1393e1c1bc12bd2d9df0d0c3877fd29893a0d3</originalsourceid><addsrcrecordid>eNp9kc1uFSEYhonR2GP1AtwYEjduZuRnBgZdNU2tJifpRteEAaZyHGDkp01vxmuVeloXLtxACM_3Bt4HgNcY9Rhh9v7Qh1p6gvDUI95jzJ6AHZ447TAZhqdghyYhOoEQPwEvcj4ghLBg4jk4oWhEhE14B35dLIvVJcO4QEy62x9wr3SJs9JuXWuG26pCUal6eLXfE44JLMmq4m0oMAZ4vVYds4XeFjXH1WUPVTBQf08xOA1dWFblvSqusS7ALVnj1GzLnzvjbpypas0f4BnMLlyvtlPJw82tscBcqrl7CZ4tDbCvHvZT8O3Txdfzz93-6vLL-dm-08PAS8dHOlJmRDvNiLKRE2qYmKniGlNBLdZ41pjMhhhhFmSQphPniyFiElQhQ0_Bu2PuluLPanOR3mVt1_Z7G2uWBA-iNd6Whr79Bz3EmkJ7XaMYQ9M4MdoofKR0ijknu8gtOa_SncRI3suTB9nkyXt5EnHZ5LWZNw_JdfbW_J14tNWAj0fAtipunE0ya2eDbqWmJlGa6P4T_xvimqs3</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2166085863</pqid></control><display><type>article</type><title>Effects of 12-wk Lactobacillus plantarum OLL2712 treatment on glucose metabolism and chronic inflammation in prediabetic individuals: A single-arm pilot study</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Toshimitsu, Takayuki ; Gotou, Ayako ; Furuichi, Keisuke ; Hachimura, Satoshi ; Asami, Yukio</creator><creatorcontrib>Toshimitsu, Takayuki ; Gotou, Ayako ; Furuichi, Keisuke ; Hachimura, Satoshi ; Asami, Yukio</creatorcontrib><description>•Lactobacillus plantarum OLL2712 is effective for individuals who are prediabetic.•The ingestion of OLL2712 cells significantly improved fasting plasma glucose levels.•Serum glycoalbumin levels and insulin resistance indexes were improved.•The intervention also suppressed serum monocyte chemotactic protein-1 and interleukin-6 levels.•OLL2712 might exert anti-diabetic effects by suppressing chronic inflammation.
Previously, we demonstrated that the administration of heat-killed OLL2712 cells suppressed chronic inflammation and improved hyperglycemia in a mouse model of obesity and diabetes. The aim of this study was to preliminarily examine the effect of OLL2712 supplementation on glucose metabolism and chronic inflammation in prediabetic subjects.
This study was a prospective, 12-wk, single-arm, open trial, followed by a 4-wk posttreatment period. Inclusion criteria were fasting plasma glucose levels of 105 to 130 mg/dL in an age range of 35 to 65 y. Thirty individuals consumed a dairy beverage containing ∼1 × 1010 heat-killed OLL2712 cells for 12 wk.
The ingestion of the OLL2712 beverage significantly improved fasting plasma glucose levels, serum glycoalbumin levels, and insulin resistance indexes compared with baseline levels. The intervention also suppressed serum monocyte chemotactic protein-1 and interleukin-6 levels, which are proinflammatory cytokines involved in the development of insulin resistance and hyperglycemia. Furthermore, stratified analysis by these proinflammatory cytokine levels revealed that the beneficial effects of OLL2712 beverage were observed particularly in individuals with chronic inflammation at baseline.
The results of this study suggested that heat-killed OLL2712 cells have the potential to improve insulin resistance and glucose metabolism by suppressing chronic inflammation.</description><identifier>ISSN: 0899-9007</identifier><identifier>EISSN: 1873-1244</identifier><identifier>DOI: 10.1016/j.nut.2018.07.116</identifier><identifier>PMID: 30502681</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Aged ; Blood Glucose - drug effects ; Blood Glucose - metabolism ; Body fat ; Cholesterol ; Chronic Disease ; Clinical trials ; Cytokines ; Diabetes ; Diabetes mellitus ; Diaries ; Diet ; Fasting ; Fasting plasma glucose ; Female ; Glucose ; Glucose metabolism ; Heat ; HOMA-IR ; Humans ; Hyperglycemia ; IL-6 ; Inflammation ; Inflammation - blood ; Inflammation - drug therapy ; Ingestion ; Insulin ; Insulin Resistance ; Interleukin 6 ; Lactobacillus plantarum ; Lipids ; Male ; MCP-1 ; Metabolic disorders ; Metabolism ; Middle Aged ; Monocyte chemoattractant protein 1 ; Monocytes ; Nutrition research ; Pilot Projects ; Prediabetic State - blood ; Prediabetic State - metabolism ; Probiotics - administration & dosage ; Probiotics - pharmacology ; Prospective Studies ; Proteins ; Serum Albumin - drug effects ; Serum Albumin - metabolism ; Supplements ; Treatment Outcome</subject><ispartof>Nutrition (Burbank, Los Angeles County, Calif.), 2019-02, Vol.58, p.175-180</ispartof><rights>2019 Elsevier Ltd</rights><rights>Copyright © 2019 Elsevier Ltd. All rights reserved.</rights><rights>Copyright Elsevier Limited Feb 2019</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c447t-753536d9c44b0365723d69b3a7c1393e1c1bc12bd2d9df0d0c3877fd29893a0d3</citedby><cites>FETCH-LOGICAL-c447t-753536d9c44b0365723d69b3a7c1393e1c1bc12bd2d9df0d0c3877fd29893a0d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0899900718309298$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30502681$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Toshimitsu, Takayuki</creatorcontrib><creatorcontrib>Gotou, Ayako</creatorcontrib><creatorcontrib>Furuichi, Keisuke</creatorcontrib><creatorcontrib>Hachimura, Satoshi</creatorcontrib><creatorcontrib>Asami, Yukio</creatorcontrib><title>Effects of 12-wk Lactobacillus plantarum OLL2712 treatment on glucose metabolism and chronic inflammation in prediabetic individuals: A single-arm pilot study</title><title>Nutrition (Burbank, Los Angeles County, Calif.)</title><addtitle>Nutrition</addtitle><description>•Lactobacillus plantarum OLL2712 is effective for individuals who are prediabetic.•The ingestion of OLL2712 cells significantly improved fasting plasma glucose levels.•Serum glycoalbumin levels and insulin resistance indexes were improved.•The intervention also suppressed serum monocyte chemotactic protein-1 and interleukin-6 levels.•OLL2712 might exert anti-diabetic effects by suppressing chronic inflammation.
Previously, we demonstrated that the administration of heat-killed OLL2712 cells suppressed chronic inflammation and improved hyperglycemia in a mouse model of obesity and diabetes. The aim of this study was to preliminarily examine the effect of OLL2712 supplementation on glucose metabolism and chronic inflammation in prediabetic subjects.
This study was a prospective, 12-wk, single-arm, open trial, followed by a 4-wk posttreatment period. Inclusion criteria were fasting plasma glucose levels of 105 to 130 mg/dL in an age range of 35 to 65 y. Thirty individuals consumed a dairy beverage containing ∼1 × 1010 heat-killed OLL2712 cells for 12 wk.
The ingestion of the OLL2712 beverage significantly improved fasting plasma glucose levels, serum glycoalbumin levels, and insulin resistance indexes compared with baseline levels. The intervention also suppressed serum monocyte chemotactic protein-1 and interleukin-6 levels, which are proinflammatory cytokines involved in the development of insulin resistance and hyperglycemia. Furthermore, stratified analysis by these proinflammatory cytokine levels revealed that the beneficial effects of OLL2712 beverage were observed particularly in individuals with chronic inflammation at baseline.
The results of this study suggested that heat-killed OLL2712 cells have the potential to improve insulin resistance and glucose metabolism by suppressing chronic inflammation.</description><subject>Adult</subject><subject>Aged</subject><subject>Blood Glucose - drug effects</subject><subject>Blood Glucose - metabolism</subject><subject>Body fat</subject><subject>Cholesterol</subject><subject>Chronic Disease</subject><subject>Clinical trials</subject><subject>Cytokines</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Diaries</subject><subject>Diet</subject><subject>Fasting</subject><subject>Fasting plasma glucose</subject><subject>Female</subject><subject>Glucose</subject><subject>Glucose metabolism</subject><subject>Heat</subject><subject>HOMA-IR</subject><subject>Humans</subject><subject>Hyperglycemia</subject><subject>IL-6</subject><subject>Inflammation</subject><subject>Inflammation - blood</subject><subject>Inflammation - drug therapy</subject><subject>Ingestion</subject><subject>Insulin</subject><subject>Insulin Resistance</subject><subject>Interleukin 6</subject><subject>Lactobacillus plantarum</subject><subject>Lipids</subject><subject>Male</subject><subject>MCP-1</subject><subject>Metabolic disorders</subject><subject>Metabolism</subject><subject>Middle Aged</subject><subject>Monocyte chemoattractant protein 1</subject><subject>Monocytes</subject><subject>Nutrition research</subject><subject>Pilot Projects</subject><subject>Prediabetic State - blood</subject><subject>Prediabetic State - metabolism</subject><subject>Probiotics - administration & dosage</subject><subject>Probiotics - pharmacology</subject><subject>Prospective Studies</subject><subject>Proteins</subject><subject>Serum Albumin - drug effects</subject><subject>Serum Albumin - metabolism</subject><subject>Supplements</subject><subject>Treatment Outcome</subject><issn>0899-9007</issn><issn>1873-1244</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kc1uFSEYhonR2GP1AtwYEjduZuRnBgZdNU2tJifpRteEAaZyHGDkp01vxmuVeloXLtxACM_3Bt4HgNcY9Rhh9v7Qh1p6gvDUI95jzJ6AHZ447TAZhqdghyYhOoEQPwEvcj4ghLBg4jk4oWhEhE14B35dLIvVJcO4QEy62x9wr3SJs9JuXWuG26pCUal6eLXfE44JLMmq4m0oMAZ4vVYds4XeFjXH1WUPVTBQf08xOA1dWFblvSqusS7ALVnj1GzLnzvjbpypas0f4BnMLlyvtlPJw82tscBcqrl7CZ4tDbCvHvZT8O3Txdfzz93-6vLL-dm-08PAS8dHOlJmRDvNiLKRE2qYmKniGlNBLdZ41pjMhhhhFmSQphPniyFiElQhQ0_Bu2PuluLPanOR3mVt1_Z7G2uWBA-iNd6Whr79Bz3EmkJ7XaMYQ9M4MdoofKR0ijknu8gtOa_SncRI3suTB9nkyXt5EnHZ5LWZNw_JdfbW_J14tNWAj0fAtipunE0ya2eDbqWmJlGa6P4T_xvimqs3</recordid><startdate>201902</startdate><enddate>201902</enddate><creator>Toshimitsu, Takayuki</creator><creator>Gotou, Ayako</creator><creator>Furuichi, Keisuke</creator><creator>Hachimura, Satoshi</creator><creator>Asami, Yukio</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RQ</scope><scope>7RV</scope><scope>7TS</scope><scope>7U7</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>201902</creationdate><title>Effects of 12-wk Lactobacillus plantarum OLL2712 treatment on glucose metabolism and chronic inflammation in prediabetic individuals: A single-arm pilot study</title><author>Toshimitsu, Takayuki ; Gotou, Ayako ; Furuichi, Keisuke ; Hachimura, Satoshi ; Asami, Yukio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c447t-753536d9c44b0365723d69b3a7c1393e1c1bc12bd2d9df0d0c3877fd29893a0d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Blood Glucose - drug effects</topic><topic>Blood Glucose - metabolism</topic><topic>Body fat</topic><topic>Cholesterol</topic><topic>Chronic Disease</topic><topic>Clinical trials</topic><topic>Cytokines</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Diaries</topic><topic>Diet</topic><topic>Fasting</topic><topic>Fasting plasma glucose</topic><topic>Female</topic><topic>Glucose</topic><topic>Glucose metabolism</topic><topic>Heat</topic><topic>HOMA-IR</topic><topic>Humans</topic><topic>Hyperglycemia</topic><topic>IL-6</topic><topic>Inflammation</topic><topic>Inflammation - blood</topic><topic>Inflammation - drug therapy</topic><topic>Ingestion</topic><topic>Insulin</topic><topic>Insulin Resistance</topic><topic>Interleukin 6</topic><topic>Lactobacillus plantarum</topic><topic>Lipids</topic><topic>Male</topic><topic>MCP-1</topic><topic>Metabolic disorders</topic><topic>Metabolism</topic><topic>Middle Aged</topic><topic>Monocyte chemoattractant protein 1</topic><topic>Monocytes</topic><topic>Nutrition research</topic><topic>Pilot Projects</topic><topic>Prediabetic State - blood</topic><topic>Prediabetic State - metabolism</topic><topic>Probiotics - administration & dosage</topic><topic>Probiotics - pharmacology</topic><topic>Prospective Studies</topic><topic>Proteins</topic><topic>Serum Albumin - drug effects</topic><topic>Serum Albumin - metabolism</topic><topic>Supplements</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Toshimitsu, Takayuki</creatorcontrib><creatorcontrib>Gotou, Ayako</creatorcontrib><creatorcontrib>Furuichi, Keisuke</creatorcontrib><creatorcontrib>Hachimura, Satoshi</creatorcontrib><creatorcontrib>Asami, Yukio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Career & Technical Education Database</collection><collection>Nursing & Allied Health Database</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Nutrition (Burbank, Los Angeles County, Calif.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Toshimitsu, Takayuki</au><au>Gotou, Ayako</au><au>Furuichi, Keisuke</au><au>Hachimura, Satoshi</au><au>Asami, Yukio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of 12-wk Lactobacillus plantarum OLL2712 treatment on glucose metabolism and chronic inflammation in prediabetic individuals: A single-arm pilot study</atitle><jtitle>Nutrition (Burbank, Los Angeles County, Calif.)</jtitle><addtitle>Nutrition</addtitle><date>2019-02</date><risdate>2019</risdate><volume>58</volume><spage>175</spage><epage>180</epage><pages>175-180</pages><issn>0899-9007</issn><eissn>1873-1244</eissn><abstract>•Lactobacillus plantarum OLL2712 is effective for individuals who are prediabetic.•The ingestion of OLL2712 cells significantly improved fasting plasma glucose levels.•Serum glycoalbumin levels and insulin resistance indexes were improved.•The intervention also suppressed serum monocyte chemotactic protein-1 and interleukin-6 levels.•OLL2712 might exert anti-diabetic effects by suppressing chronic inflammation.
Previously, we demonstrated that the administration of heat-killed OLL2712 cells suppressed chronic inflammation and improved hyperglycemia in a mouse model of obesity and diabetes. The aim of this study was to preliminarily examine the effect of OLL2712 supplementation on glucose metabolism and chronic inflammation in prediabetic subjects.
This study was a prospective, 12-wk, single-arm, open trial, followed by a 4-wk posttreatment period. Inclusion criteria were fasting plasma glucose levels of 105 to 130 mg/dL in an age range of 35 to 65 y. Thirty individuals consumed a dairy beverage containing ∼1 × 1010 heat-killed OLL2712 cells for 12 wk.
The ingestion of the OLL2712 beverage significantly improved fasting plasma glucose levels, serum glycoalbumin levels, and insulin resistance indexes compared with baseline levels. The intervention also suppressed serum monocyte chemotactic protein-1 and interleukin-6 levels, which are proinflammatory cytokines involved in the development of insulin resistance and hyperglycemia. Furthermore, stratified analysis by these proinflammatory cytokine levels revealed that the beneficial effects of OLL2712 beverage were observed particularly in individuals with chronic inflammation at baseline.
The results of this study suggested that heat-killed OLL2712 cells have the potential to improve insulin resistance and glucose metabolism by suppressing chronic inflammation.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>30502681</pmid><doi>10.1016/j.nut.2018.07.116</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0899-9007 |
| ispartof | Nutrition (Burbank, Los Angeles County, Calif.), 2019-02, Vol.58, p.175-180 |
| issn | 0899-9007 1873-1244 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2149016490 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Adult Aged Blood Glucose - drug effects Blood Glucose - metabolism Body fat Cholesterol Chronic Disease Clinical trials Cytokines Diabetes Diabetes mellitus Diaries Diet Fasting Fasting plasma glucose Female Glucose Glucose metabolism Heat HOMA-IR Humans Hyperglycemia IL-6 Inflammation Inflammation - blood Inflammation - drug therapy Ingestion Insulin Insulin Resistance Interleukin 6 Lactobacillus plantarum Lipids Male MCP-1 Metabolic disorders Metabolism Middle Aged Monocyte chemoattractant protein 1 Monocytes Nutrition research Pilot Projects Prediabetic State - blood Prediabetic State - metabolism Probiotics - administration & dosage Probiotics - pharmacology Prospective Studies Proteins Serum Albumin - drug effects Serum Albumin - metabolism Supplements Treatment Outcome |
| title | Effects of 12-wk Lactobacillus plantarum OLL2712 treatment on glucose metabolism and chronic inflammation in prediabetic individuals: A single-arm pilot study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T09%3A19%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%2012-wk%20Lactobacillus%20plantarum%20OLL2712%20treatment%20on%20glucose%20metabolism%20and%20chronic%20inflammation%20in%20prediabetic%20individuals:%20A%20single-arm%20pilot%20study&rft.jtitle=Nutrition%20(Burbank,%20Los%20Angeles%20County,%20Calif.)&rft.au=Toshimitsu,%20Takayuki&rft.date=2019-02&rft.volume=58&rft.spage=175&rft.epage=180&rft.pages=175-180&rft.issn=0899-9007&rft.eissn=1873-1244&rft_id=info:doi/10.1016/j.nut.2018.07.116&rft_dat=%3Cproquest_cross%3E2149016490%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2166085863&rft_id=info:pmid/30502681&rft_els_id=S0899900718309298&rfr_iscdi=true |